3 Firms Vie To Lead Investor Suit Against Mass. Biotech Co.
By Brian Dowling (August 3, 2021, 1:40 PM EDT) -- Glancy Prongay & Murray LLP, Levi & Korsinsky LLP and Scott + Scott Attorneys at Law LLP filed competing bids in Massachusetts federal court Monday to represent investors in a class action against Frequency Therapeutics Inc., which allegedly hid bad clinical trial results for its hearing loss treatment while executives dumped their stakes.
Two putative class actions filed against Frequency Therapeutics in June claimed the Woburn-based biotech company knew that clinical trials of its FX-322 treatment for patients with sensorineural hearing loss showed the drug was not performing better than the placebo and repeatedly delayed releasing the trial group results.
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!